Aging and Disease' editorial, publishing and peer
review policies help us maintain the highest standards for which we are known
Editorial and publishing policies
AD upholds strict editorial and publishing policies to
ensure the quality, integrity, and transparency of the content it publishes.
The following guidelines outline the key aspects of AD's editorial and
Review Process: a. All manuscripts submitted to AD undergo a rigorous peer
review process by experts in the field to ensure scientific rigor,
accuracy, and relevance. b. Reviewers provide constructive feedback to
authors and make recommendations regarding the acceptance, revision, or
rejection of the manuscript.
Independence: a. Editorial decisions are made independently by the
editorial team based on the scientific merit and significance of the
research presented in the manuscripts. b. Decisions are not influenced by
commercial interests, personal relationships, or any external factors
unrelated to the scientific content.
and Acknowledgments: a. Authorship should be based on substantial
contributions to the conception, design, analysis, interpretation of data,
and drafting of the manuscript. b. All individuals who have made
significant contributions but do not meet the criteria for authorship
should be acknowledged appropriately. c. Any conflicts of interest or
funding sources relevant to the study must be disclosed.
and Ethical Standards: a. AD has a strict policy against plagiarism,
duplicate publication, and research misconduct. b. Submitted manuscripts
are screened for potential plagiarism using advanced plagiarism detection
tools. c. Authors are expected to adhere to the highest ethical standards
and ensure the accuracy, originality, and integrity of their work.
Retractions, and Expressions of Concern: a. AD is committed to promptly
correcting any errors or inaccuracies identified in published articles. b.
Corrections, retractions, or expressions of concern may be issued when
necessary, following established guidelines and best practices.
Availability and Reproducibility: a. Authors are encouraged to make the
data underlying their findings available and accessible to readers
whenever possible. b. Reproducibility and transparency in research
methodology are highly valued by AD.
Access and Licensing: a. AD is open access publishing to promote the
widespread dissemination of research findings. b. Articles published under an open access Creative Common CC BY
license may be reused without permission
provided that the original article is clearly cited.
and Permissions: a. Authors retain the copyright of their published work,
granting AD a non-exclusive license to publish the article. b. Proper
attribution and citation of previously published work are essential, and
authors are responsible for obtaining necessary permissions.
Board and Conflict of Interest: a. AD's Editorial Board members are
selected based on their expertise, experience, and commitment to advancing
research in the field of aging and disease. b. Editorial Board members are
required to disclose any potential conflicts of interest and recuse
themselves from editorial decisions when conflicts arise.
Integrity and Quality Control: a. AD is committed to maintaining the
highest standards of editorial integrity and quality control. b. The editorial
team reviews all published content to ensure accuracy, clarity, and
adherence to AD's editorial policies.
These editorial and publishing policies are regularly
reviewed and updated to align with emerging best practices and ethical
standards in scientific publishing. By adhering to these policies, AD aims to
provide a trusted platform for high-quality research in the field of aging and
disease and contribute to the advancement of scientific knowledge.
Peer review policies
We have rigorous policies to govern every stage and aspect
of our peer review process, from initial submission through to revisions,
decisions and appeals.
To find out more, please visit our peer review policies page.
Conflict of Interest Policies
Aging and Disease (AD) adheres to a strict Conflict of
Interest policy to ensure the integrity and credibility of published research.
This policy applies to all authors, reviewers, and editors involved in the
Conflict of Interest: a. Authors are required to disclose any financial,
professional, or personal relationships that could potentially influence
their research or the interpretation of their findings. b. These
relationships include but are not limited to employment, consultancies,
honoraria, ownership interests, patent applications, and funding sources
related to research. c. Authors must provide a comprehensive statement of
disclosure in their manuscript, indicating any conflicts of interest or
declaring no conflicts, to maintain transparency.
and Editors' Conflict of Interest: a. Reviewers and editors involved in
the peer review process must disclose any conflicts of interest that could
compromise their objectivity. b. Reviewers or editors who have a personal,
financial, or professional relationship with the authors should decline
the invitation to review or handle the manuscript. c. In cases where a
reviewer or editor becomes aware of a conflict of interest during the
review process, they should promptly notify the editorial office.
of Conflicts of Interest: a. The editorial office will review all
disclosed conflicts of interest and take appropriate actions to ensure the
integrity of the publication process. b. If conflicts of interest are
identified, the editorial office may consider alternative reviewers or
editors to evaluate the manuscript. c. In cases where the conflicts of
interest are deemed significant, the editorial office reserves the right to
reject the manuscript or request revision and additional disclosures.
a. AD will include a Conflict of Interest statement alongside each
published article, providing readers with complete information regarding
potential conflicts. b. The Conflict of Interest statement will indicate
whether any conflicts of interest were disclosed by the authors,
reviewers, or editors involved in the publication.
By adhering to this Conflict of Interest policy, AD ensures
the highest ethical standards in scientific publishing and upholds the
integrity of the research presented.
Human and Animal Rights
AD is committed to upholding ethical standards and promoting
the protection of human and animal rights in research. Authors, reviewers, and
editors involved in the publication process are expected to comply with the
Rights: a. Authors must ensure that all research involving human
participants has been conducted in accordance with relevant national and
international guidelines and regulations. b. Authors should provide clear
descriptions of the ethical considerations and procedures followed,
including obtaining informed consent from participants, ensuring
confidentiality, and protecting the rights and welfare of vulnerable
populations. c. Informed consent should be obtained from human
participants, and any potential risks or benefits should be clearly
Rights: a. Authors should adhere to internationally recognized guidelines
for the care and use of animals in research, such as the principles
outlined in the Guide for the Care and Use of Laboratory Animals. b. The
study involving animals must have received approval from an appropriate
institutional ethics committee or review board. c. Authors should provide
detailed information regarding the methods used to minimize animal
suffering, including appropriate anesthesia and analgesia, as well as
efforts to reduce the number of animals used.
Ethical Compliance: a. Authors must clearly state in their manuscript that
the research was conducted in accordance with ethical guidelines and
provide relevant details of the ethical approval obtained. b. In cases
where ethical approval was not required, authors should clearly explain
the reasons for exemption.
and Privacy: a. Authors should respect the privacy and confidentiality of
individuals involved in the research and ensure that any personal
information or identifying details are appropriately anonymized or
removed. b. Any photographs or images of individuals should be accompanied
by written permission for their use and publication.
with Regulations: a. Authors should comply with all relevant laws and
regulations governing research involving human subjects and animals, as
well as any institutional or national guidelines.
The AD editorial team reserves the right to assess the
ethical compliance of submitted manuscripts and may request additional
information or clarification from authors. Non-compliance with ethical
guidelines may result in rejection of the manuscript.
By adhering to this Human and Animal Rights policy, AD aims
to promote ethical research practices, protect the rights of participants, and
contribute to the advancement of knowledge in the field of aging and disease
while ensuring the well-being of humans and animals involved in the research
Informed Consent Policies
Patient privacy is crucial and should never be violated
without informed consent. Personal details should not be disclosed unless
essential for scientific purposes with explicit written consent. Identifiable
patients should review the manuscript before publication. Authors must inform
patients about potential online and print availability. Written consent should
be obtained, following regulations, and nonessential identifying details should
be omitted. Informed consent is necessary when anonymity is uncertain.
Alterations to protect identity must not distort scientific meaning.
Publication should indicate when informed consent is obtained.
AD maintains an advertising policy to ensure the integrity,
independence, and transparency of the journal's content. The following
guidelines apply to all advertisements featured in AD:
Independence: a. Advertising content must not influence the editorial
decisions or compromise the scientific integrity of AD. b. The acceptance
of advertisements does not imply endorsement or support of the advertised product
or service by AD or its affiliated institutions.
and Appropriateness: a. Advertisements should be relevant to the scope and
interests of AD's readership, which primarily focuses on aging and disease
research and related topics. b. Advertisements should be appropriate for a
professional, scientific audience and should not contain misleading,
false, or offensive content.
from Editorial Content: a. Advertisements should be clearly
distinguishable from editorial content to avoid confusion. b. Advertising
placements should be visually separated or clearly labeled as
'Advertisement' or 'Ad' to ensure transparency.
Claims and Accuracy: a. Advertisements should provide accurate and
verifiable information about products or services being promoted. b.
Scientific claims made in advertisements should be supported by
appropriate evidence and adhere to ethical and regulatory standards.
of Conflict of Interest: a. Advertisers must disclose any conflicts of
interest related to the advertised product or service. b. AD reserves the
right to request additional information regarding conflicts of interest
from advertisers if deemed necessary.
and Approval: a. All advertisements are subject to review and approval by
the AD editorial team. b. AD reserves the right to reject or remove
advertisements that are deemed inconsistent with the advertising policy or
that may negatively impact the journal's reputation.
and Design: a. The placement of advertisements within the journal will be
determined by AD in a manner that ensures clarity, visibility, and
appropriate context. b. Advertisements should adhere to any specified
design specifications and file formats provided by AD.
The AD editorial team regularly monitors advertisements to
ensure ongoing compliance with the advertising policy. If any concerns or
complaints arise regarding an advertisement, AD encourages readers and stakeholders
to contact the editorial office for prompt review and appropriate action.
The process for handling cases requiring corrections, retractions, and editorial expressions of concern
AD follows a well-defined process for handling cases that
require corrections, retractions, or editorial expressions of concern. The
objective is to maintain the integrity of the published content and promptly
address any issues identified. The following guidelines outline the process:
of Concerns: a. Concerns about published articles may be raised by
readers, authors, reviewers, or other stakeholders. b. Concerns may
include, but are not limited to, errors, omissions, plagiarism, research
misconduct, or ethical violations.
Investigation: a. The editorial team reviews the nature and seriousness of
the concerns raised. b. If the concerns are deemed substantial, an
investigation is initiated.
a. The editor-in-chief may consult with relevant experts, authors,
reviewers, or the editorial board to gather additional insights and
perspectives. b. The investigation may involve seeking input from the
authors involved in the published work.
a. Based on the findings of the investigation and consultations, the
editor-in-chief makes a decision regarding the appropriate course of
action. b. Possible outcomes include corrections, retractions, expressions
of concern, or no action, depending on the nature and severity of the
a. Minor errors or inaccuracies in published articles may be addressed
through a correction notice. b. Corrections should clearly identify the
errors and provide accurate information to rectify the published record.
a. In cases of serious ethical violations, research misconduct, or
irreproducibility, retractions may be necessary. b. Retraction notices
should provide a clear and concise explanation of the reasons for
retraction, ensuring transparency and maintaining the integrity of the
Expressions of Concern: a. In situations where there are concerns about
the integrity or reliability of published work but further investigation
is required, an editorial expression of concern may be issued. b.
Editorial expressions of concern inform readers about the ongoing
investigation and highlight the need for caution when interpreting the
and Transparency: a. The decisions regarding corrections, retractions, or
editorial expressions of concern are communicated to the authors, readers,
and relevant stakeholders. b. The concerns raised, investigations
conducted, and outcomes are documented to ensure transparency and
Updates: a. Once corrections, retractions, or expressions of concern are
published, they are clearly linked to the original article to provide
readers with the updated information.